Adjuvant therapy with bemiparin in patients with limited-stage small cell lung cancer: results from the ABEL study. [electronic resource]
Producer: 20140909Description: 666-70 p. digitalISSN:- 1879-2472
- Anticoagulants -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- Disease-Free Survival
- Etoposide -- administration & dosage
- Female
- Hemorrhage -- drug therapy
- Heparin, Low-Molecular-Weight -- adverse effects
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Small Cell Lung Carcinoma -- drug therapy
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.